Ioannidis and team respond to criticisms of Santa Clara SARS-CoV-2 study (medrxiv.org) 1 points by statquontrarian 6y ago ↗ HN
0 comments
[ 1656 ms ] story [ 126 ms ] threadNo comments yet.